Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating chemotherapy plus bone marrow transplantation with filgrastim in patients with acute myeloid leukemia or myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Neupogen (Filgrastim)

Snippet

Sponsor: Northwestern University | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED